Key result
Cardiovascular autonomic neuropathy linked to ~345% higher risk of diabetic foot ulcers in T2D without polyneuropathy.
Why the study?
The factors influencing the development of diabetic foot ulcers in type 2 diabetes patients without diabetic polyneuropathy were unclear.
Does the presence of cardiovascular autonomic neuropathy predict the development of diabetic foot ulcers in patients with type 2 diabetes without diabetic polyneuropathy?
Cohort (n=595)
Does the presence of cardiovascular autonomic neuropathy predict the development of diabetic foot ulcers in patients with type 2 diabetes without diabetic polyneuropathy?
Hazard Ratio: 4.45 (95% CI 1.29–15.33)
Cardiovascular autonomic neuropathy is an independent predictor of diabetic foot ulcers in patients with type 2 diabetes even in the absence of diabetic polyneuropathy.
May support neuropathy screening for ulcer risk stratification in type 2 diabetes; leaves open causal role and need for prospective trials.
We investigated the factors that might influence the development of diabetic foot ulcers (DFUs) in type 2 diabetes patients without diabetic polyneuropathy (DPN).From January 2000 to December 2005, a total of 595 patients who had type 2 diabetes without DPN between the ages of 25 and 75 years, and had no prior history of DFUs were consecutively enrolled in the study. A cardiovascular autonomic function test was performed to diagnose cardiovascular autonomic neuropathy (CAN) using heart rate variability parameters.The median follow-up time was 13.3 years. Among the 449 (75.4%) patients who completed the follow-up evaluation, 22 (4.9%) patients developed new ulcers, and 6 (1.3%) patients underwent the procedure for lower extremity amputations. The patients in the DFUs group had a longer duration of diabetes, higher baseline HbA1c levels, higher rates of nephropathy, and CAN. A Cox hazard regression analysis results revealed that the development of DFUs was significantly associated with the presence of CAN (normal vs definite CAN; HR, 4.45; 95% confidence interval, 1.29-15.33) after adjusting for possible confounding factors.The development of DFUs was independently associated with CAN in patients with type 2 diabetes without DPN. We suggested the importance of CAN as a predictor of DFUs even in the patients without DPN, and the need to pay attention to patients with definite CAN and type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Yun et al. (2016) conducted a cohort in Type 2 diabetes without diabetic polyneuropathy (n=595). Cardiovascular autonomic neuropathy (CAN) vs. Normal (no CAN) was evaluated on Development of diabetic foot ulcers (DFUs) (HR 4.45, 95% CI 1.29-15.33). Definite cardiovascular autonomic neuropathy was significantly associated with the development of diabetic foot ulcers in patients with type 2 diabetes without polyneuropathy (HR 4.45; 95% CI 1.29-15.33).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: